Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Grant or award SVP, Chief Development Officer acquired 23,000 shares (grant or award)
  2. 4 Grant or award SVP and Chief Medical Officer acquired 23,500 shares (grant or award)
  3. 4 Grant or award SVP, General Counsel, Sec. acquired 28,500 shares (grant or award)
  4. 4 Grant or award CEO and President acquired 119,500 shares (grant or award)
  5. 4 Grant or award SVP, CFO & Treasurer acquired 30,000 shares (grant or award)
  6. 5 Insider Annual Insider Trading Report
  7. 4 Exercise or conversion CEO and President acquired 20,000 shares (option exercise)
  8. 4 Open-market sale SVP, Chief Business Officer sold 1,629 shares at $10.49 ($17,089)
  9. 4 Open-market sale Director sold 1,980 shares at $10.46 ($20,711)
  10. 4 Open-market sale SVP, General Counsel, Sec. sold 1,810 shares at $10.49 ($18,988)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market sale Director sold 1,981 shares at $8.96 ($17,746)
  14. 4 Open-market sale SVP, Chief Business Officer sold 1,401 shares at $8.95 ($12,546)
  15. 4 Open-market sale SVP, General Counsel, Sec. sold 1,556 shares at $8.95 ($13,934)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale Director sold 1,980 shares at $7.48 ($14,819)
  19. 4 Open-market sale SVP, Chief Business Officer sold 1,402 shares at $7.47 ($10,468)
  20. 4 Open-market sale SVP, General Counsel, Sec. sold 1,557 shares at $7.47 ($11,625)

Page 14 of 19 · 378 filings